EUROPEAN JOURNAL OF OPHTHALMOLOGY, cilt.27, sa.3, ss.319-325, 2017 (SCI-Expanded)
Purpose: To evaluate the safety and efficacy of accelerated corneal crosslinking (CXL) in patients with progressive keratoconus aged 18 years or less.